Literature DB >> 16451352

Increased interleukin-6 messenger RNA expression in macrophage-cocultured endometrial stromal cells in adenomyosis.

Jehn-Hsiahn Yang1, Ming-Yih Wu, Daw-Yuan Chang, Chien-Huei Chang, Yu-Shih Yang, Hong-Nerng Ho.   

Abstract

PROBLEM: To determine the effects of macrophage on endometrial stromal cells (ESCs) in women with adenomyosis. METHOD OF STUDY: Eutopic endometrium was obtained and separated into single ESC in 10 women with adenomyosis (study group) and 11 without adenomyosis (control group). ESCs were then cultured alone or with macrophage for 24 hr.
RESULTS: Immunohistochemistry identified the presence of interleukin-6 (IL-6), IL-8, and IL-10 in ESCs. Real-time quantitative PCR revealed that the IL-6 mRNA was significantly expressed in macrophage-cocultured ESCs in adenomyosis than that in the controls, but was not different in ESCs cultured alone between the two groups. The levels of IL-8 and IL-10 mRNA were similar in ESCs either cultured alone or with macrophage between women with and without adenomyosis.
CONCLUSION: IL-6 mRNA was significantly expressed in ESCs after in vitro coculture with macrophage in adenomyosis. This aberrant behavior of ESCs might play a role in the formation of ectopic endometrial implants in adenomyosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16451352     DOI: 10.1111/j.1600-0897.2005.00363.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  11 in total

1.  L-22 enhances the invasiveness of endometrial stromal cells of adenomyosis in an autocrine manner.

Authors:  Qing Wang; Li Wang; Jun Shao; Yan Wang; Li-Ping Jin; Da-Jin Li; Ming-Qing Li
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

2.  Blocking IL-22, a potential treatment strategy for adenomyosis by inhibiting crosstalk between vascular endothelial and endometrial stromal cells.

Authors:  Wen-Qing Shang; Jia-Jun Yu; Lei Zhu; Wen-Jie Zhou; Kai-Kai Chang; Qing Wang; Ming-Qing Li
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

3.  Pathology and Pathogenesis of Adenomyosis.

Authors:  Maria Facadio Antero; Ayse Ayhan; James Segars; Ie-Ming Shih
Journal:  Semin Reprod Med       Date:  2020-10-20       Impact factor: 1.303

4.  Infertility and adenomyosis.

Authors:  Sebastiano Campo; Vincenzo Campo; Giuseppe Benagiano
Journal:  Obstet Gynecol Int       Date:  2011-12-26

Review 5.  The Impact of Adenomyosis on Women's Fertility.

Authors:  Tasuku Harada; Yin Mon Khine; Apostolos Kaponis; Theocharis Nikellis; George Decavalas; Fuminori Taniguchi
Journal:  Obstet Gynecol Surv       Date:  2016-09       Impact factor: 2.347

6.  Clinical outcomes of infertility treatment for women with adenomyosis in Japan.

Authors:  Hiroshi Tamura; Hiroshi Kishi; Mari Kitade; Mikiko Asai-Sato; Atsushi Tanaka; Takashi Murakami; Takashi Minegishi; Norihiro Sugino
Journal:  Reprod Med Biol       Date:  2017-05-16

7.  Transcriptome analysis of endometrial tissues following GnRH agonist treatment in a mouse adenomyosis model.

Authors:  Song Guo; Xiaowei Lu; Ruihuan Gu; Di Zhang; Yijuan Sun; Yun Feng
Journal:  Drug Des Devel Ther       Date:  2017-03-09       Impact factor: 4.162

8.  Window of Implantation is Significantly Displaced in Patients with Adenomyosis with Previous Implantation Failure as Determined by Endometrial Receptivity Assay.

Authors:  Nalini Mahajan; Simrandeep Kaur; Maria Ruiz Alonso
Journal:  J Hum Reprod Sci       Date:  2018 Oct-Dec

9.  Transcriptome sequencing of adenomyosis eutopic endometrium: A new insight into its pathophysiology.

Authors:  Yuqian Xiang; Yabing Sun; Bingxin Yang; Yeping Yang; Ying Zhang; Tiantian Yu; Hefeng Huang; Junyu Zhang; Hong Xu
Journal:  J Cell Mol Med       Date:  2019-10-01       Impact factor: 5.310

10.  Activation of the cGAS-STING signaling pathway in adenomyosis patients.

Authors:  Yun Lin; Luying Wang; Mingzhu Ye; Ke-Nan Yu; Xin Sun; Min Xue; Xinliang Deng
Journal:  Immun Inflamm Dis       Date:  2021-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.